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SEffect of sympathectomy level on the incidence of compensatory
hyperhidrosis after sympathectomy for palmar hyperhidrosis
Daniel L. Miller, MD, Ayesha S. Bryant, MSPH, MD, Seth D. Force, MD, and Joseph I. Miller, Jr, MD
Objective: Palmar hyperhidrosis can be psychosocially devastating. Sympathectomy provides effective treat-
ment. The most common side effect after sympathectomy is compensatory hyperhidrosis, which can be debilitat-
ing. Controversy exists as to which and how many levels treated carry the lowest incidence of compensatory
hyperhidrosis after sympathectomy for palmar hyperhidrosis.
Methods: Retrospective review was conducted on a video-assisted thoracoscopic surgical database including all
patients who underwent video-assisted thoracoscopic surgical sympathectomy for palmar hyperhidrosis.
Results: Video-assisted sympathectomy was performed in 282 patients for palmar hyperhidrosis fromMay 2002
through July 2005; in all, 179 patients (64%) underwent division at T2 level only and 103 at levels T2, T3, and
T4. The groups were similar in age and sex distribution. The rate of compensatory hyperhidrosis was significantly
less in the T2 group (23 patients, 13%) than in the T2 through T4 group (35 patients, 34%)(P¼ .011). The most
common site of compensatory hyperhidrosis in both groups was the lower back. Patients with compensatory hy-
perhidrosis were older (median 31 years vs 23 years, P¼ .037), had body mass index greater than 28 (P¼ .048),
and underwent multiple level sympathectomy (P ¼ .004).
Conclusion: Compensatory hyperhidrosis continues to occur after sympathectomy for palmar hyperhidrosis;
however, a significant reduction in incidence can be achieved by dividing the sympathetic chain at a single level
(T2). Patients who are older and/or have increased body mass index should be warned of their increased risk of
compensatory hyperhidrosis after sympathectomy.
GENERALTHORACIC SURGERYHyperhidrosis is the secretion of sweat in amounts greater
than physiologically needed for thermoregulation. It is
most commonly an idiopathic condition. Idiopathic hyperhi-
drosis, also referred to as primary or focal hyperhidrosis,
usually affects the face, axillae, palms, or soles. Medical
management is often frustrating, and the response is usually
transient. Surgical therapy is effective and is based on the in-
terruption of transmission of impulses from the sympathetic
ganglia to the sweat glands. Currently, a video-assisted tho-
racic surgical approach to sympathectomy is preferred.
Compensatory hyperhidrosis (CH) is the most common
side effect of this procedure and is the most common reason
for patients to forego sympathectomy. CH is generally
considered to be a reactive thermoregulatory mechanism,
with the extent of sympathectomy believed to influence its
severity and frequency. In this series, two different surgical
philosophies with regard to the treatment of palmar hyperhi-
drosis (PH) were reviewed. One surgeon (J.I.M.) performs
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whereas two other surgeons (D.L.M. and S.D.F.) divide
the chain at a single level (T2). Use of the latter technique
at our institution has been described previously.1 Because
these two different techniques are being performed within
in a single health care system for the same indication, we
decided to compare the incidences of CH associated with
these procedures to determine whether one technique is pre-
ferable for relief of excessive palmar sweating.
MATERIALS AND METHODS
Data were collected on a consecutive series of patients who underwent
video-assisted thoracic surgical sympathectomy for medically refractory
primary PH within the Emory Healthcare System from May 2002 through
July 2005 by three different thoracic surgeons. The medical record, opera-
tive report, anesthesia record, and clinic charts were examined for each
patient. Follow-up information was obtained from medical records and
clinic charts. A postsympathectomy questionnaire was completed by each
patient at the time of the postoperative visit, usually at 4 weeks. Specific
questions detailed incidence of CH, other side effects of the procedure, post-
operative pain, and satisfaction with the procedure. This studywas approved
by the Emory University institutional review board.
Statistical Methods
Data were stored with Excel spreadsheet software (Microsoft Corpora-
tion, Redmond, Wash), and analyses were performed with SAS 9.0 statisti-
cal software (SAS Institute, Inc, Cary, NC). Categoric values were
compared with analysis of variance, the c2 test, or the Fisher exact test.
Continuous variables were compared with the Student t test for normally
distributed variables and theWilcoxon test for nonnormally distributed vari-
ables.Multivariate regression analysis was used to identify independent var-
iables that were related to CH.ardiovascular Surgery c Volume 138, Number 3 581
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SAbbreviations and Acronyms
BMI ¼ body mass index
CH ¼ compensatory hyperhidrosis
PH ¼ palmar hyperhidrosis
Clinical Findings
There were 265 women (94%) and 17 men who underwent sympathec-
tomy for PH.Median age was 24 years (range 14–62 years). All patients had
been evaluated for secondary causes of hyperhidrosis. The final diagnosis in
all 282 cases was primary PH of unknown etiology. Plantar hyperhidrosis
was also present in 163 patients (59%). Medical treatment was exhausted
in all cases before consideration for sympathectomy. Previous medical treat-
ment consisted of topical agents (most commonly aluminum chloride) in all
282 cases (100%), oral medications (glycopyrrolate [Robinul, INN glyco-
pyrronium bromide], propantheline bromide [Pro-Bathine], or b-blockers)
in 223 (79%), iontophoresis in 51 (18%), palmar onabotulinumtoxinA
(Botox, INN botulinum toxin type A) injections in 16 (6%), and other treat-
ments in 85 (30%). Median period of medical treatment before sympathec-
tomywas 59months (range 3–480months); 39 patients (14%) had a first- or
second-degree relative with PH.
Surgical Technique
Sympathectomy was performed by two different procedures, depending
on surgeon preference. The first procedure (D.L.M. and S.D.F.) was
performed on an outpatient basis within the main operating room or in
our ambulatory surgical center. The patients were placed in a supine posi-
tion. General anesthesia was initiated with a single-lumen endotracheal
tube. After the patient was asleep, the arms were extended to 90. Excessive
abduction of the upper extremities was avoided to prevent injury to the bra-
chial plexus. Temperature probes were placed on each index finger. Each
axilla was prepared in standard fashion. Attention was first directed to the
right side. A single 4-mm incision was made vertically over the fourth rib
along the midaxillary line. With a mosquito clamp, the chest cavity was en-
tered over the fourth rib during suspension of ventilation. During continued
ventilation suspension, a 3-mm, 30 rigid thoracoscope (KARL STORZ
GmbH&Co KG, Tuttlingen, Germany) was placed. Alongside the thoraco-
scope, a standard laparoscopic Veress needle (Ethicon, Inc, Somerville, NJ)
was placed. After the two instruments had been placed without difficulty,
ventilation was resumed at decreased tidal volumes of 250 mL for women
and 300 mL for men. Carbon dioxide insufflation was carried out to
10 mm Hg for approximately 60 to 90 seconds to allow partial collapse
of the lung. The Veress needle was removed, and a 2-mm long electrocau-
tery was placed through the same incision. A detailed examination of the
apical and posterior chest was carried out for accurate identification of the
anatomy of the sympathetic chain and its accessory nerves. Before division
of the nerve, a finger temperature was taken for baseline measurement. The
sympathetic chain was then divided over the second rib to complete the T2
sympathectomy, with all accessory nerves also divided with electrocautery.
The cauterized ends of the nerves were separated from each other to allow at
least a 1.0- to 1.5-cm gap, to diminish the chance of regrowth and possible
recurrence of PH. A posttreatment temperature was taken 5 minutes after
complete division of the nerve. The sympathectomy site was examined
for hemostasis. A 2-mm suction catheter was then placed to the apex of
the chest under direct visualization. The external end of the catheter was
placed in a basin of sterile water to create a water seal to evacuate the pneu-
mothorax. By means of sterile water immersion of the catheter, positive-
pressure ventilation to 40 mm Hg, and suctioning, the pneumothorax was
evacuated. After the pneumothorax had been evacuated, the catheter was
removed. The skin was reapproximated with octylcyanoacrylate (Derma-
bond; Ethicon) adhesive and Steri-Strips (3M, St Paul, Minn). The left582 The Journal of Thoracic and Cardiovascular Suside was completed in similar fashion. A 15-mL dose of 0.25% bupivacaine
(Marcaine) was injected into each incision site before making the incision
and at the time of closure. Also, 30 mg ketorolac was given intravenously
before making the first incision.
The other sympathectomyprocedure (J.I.M.)was usually performed as an
inpatient procedure (observation stay) within our hospital’s main operating
room. General anesthesia was initiated with a double-lumen endotracheal
tube.Thepatientwas placed in a lateral decubitusposition to facilitate a trans-
axillary approach. The axillae were prepared in standard fashion. Attention
was first directed to the right side. A 3- to 5-cm incision was placed in the
axilla over the third rib. The chest cavity was entered over the third rib after
initiation of single-lung anesthesia. During complete collapse of the lung,
a 10-mm, 30 rigid thoracoscope (KARL STORZ) was placed. Detailed ex-
amination of the apical and posterior chest was carried out to identify accu-
rately the anatomy of the sympathetic chain and its accessory nerves. The
sympathetic chain was then divided over the second, third, and fourth ribs
to complete theT2 toT4 sympathectomywith a standard long electrocautery.
All accessory nerves were also divided with electrocautery. The cauterized
ends of the nerves were separated from each other to allow at least a 1.0-
to 1.5-cm gap to diminish the chance of regrowth and possible recurrence
of PH. A 14F red rubber catheter was then placed to the apex of the chest un-
der direct visualization. The external end of the catheter was placed in a basin
of sterile water to create a water seal to evacuate the pneumothorax. With
sterile water immersion of the catheter and positive pressure ventilation to
40 mm Hg, the pneumothorax was evacuated. After the pneumothorax had
been evacuated, the catheter was removed. The incision was closed in layers
in the usual fashion. The left side was completed in similar fashion after re-
positioning the patient in the right lateral decubitus fashion. Sterile dressings
were applied and the patient was taken to the recovery room.
In the recovery room, an upright chest radiograph was obtained approx-
imately 30 minutes after completion of the procedure. If the chest radiogra-
phy was satisfactory and the patient was having minimal pain, the patient
could be discharged after the T2 procedure but was usually observed over-
night after the T2 to T4 procedure. Patients were asked to return to the clinic
within 3 to 4 weeks after the procedure for follow-up.
Sympathectomies were completed bilaterally in all patients with division
of the nerve at the T2 level or T2 to T4 level, respectively. Anatomically,
106 patients (38%) had accessory nerves, right-sided in 49, left-sided in
32, and bilateral in 25. All identified accessory nerves were also divided
to complete the sympathectomy. Median operating times were 22 minutes
(range 14–50 minutes) in the T2 group and 59 minutes (range 42–73
minutes) in the T2 to T4 group. Seven patients (2%) had a chest tube
(10F) placed at the time of sympathectomy because of lysis of adhesions
between the apex of the chest cavity and the lung; 6 (86%) of the chest tubes
were removed within 4 hours.
RESULTS
Video-assisted thoracic surgical sympathectomy for PH
was performed in 282 patients from May 2002 through
July 2005; of these, 179 patients (64%) underwent division
at the T2 level only and 103 patients(36%) underwent divi-
sion at levels T2, T3, and T4. Median age, sex distribution,
body mass index (BMI), and morbidity rate were similar
between the groups (Table 1). The most common operative
complication was pneumothorax in 6 patients (2%), and
none of these patients had symptoms or required treatment.
There were no operative deaths. Additionally, the satisfac-
tion rate as detailed during postoperative visit was also sim-
ilar between groups of patients. Patients who had division of
the sympathetic chain at multiple levels, however, had a sig-
nificantly higher incidence of CH (P ¼ .026).rgery c September 2009
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from 1 to 42 months (median 26 months). CH developed
in 58 patients (21%), 23 in the T2 group and 35 in T2 to
T4 group. In both groups, the most common areas of CH
were the lower back and abdomen. Ten patients with CH
(17%) required pharmaceutical interventions. Most patients
reported a decrease or near complete resolution of CHwithin
6 to 9 months after surgery. Five patients (2%), however,
stated that they wished that they had not undergone the
procedure because of unrelenting CH even though their
PH resolved; 4 patients (80%) were in the multilevel group
and only 1 in the T2 group. Multivariate regression analysis
demonstrated that multiple level sympathetic chain division,
greater BMI, and older age were independent predictors for
development of CH (Table 2).
Successful sympathectomy was achieved for 99% of
palmar surfaces without recurrence. A single patient had
recurrent sweating of the left hand 1 week after sympathec-
tomy. Reoperation was performed 4 weeks after the sympa-
thectomy, with division at the T3 level. The patient had no
accessory nerves identified. The reoperation was successful
without development of CH.
DISCUSSION
Sympathectomy for medical refractory primary PH is
extremely successful. The incidence of CH is disturbing,
however, and varies depending on the indication for the
procedure, level of sympathectomy, and the number of
levels treated.2-5 Controversy exists regarding which and
how many levels should be divided. Hsu and colleagues6
demonstrated a significant reduction in the incidence of
CH after switching from a T2 to T4 sympathectomy to
a T2 sympathectomy, with CH reduced from 64% to
25%. Early in our experience, we routinely performed
a three level (T2–T4) sympathectomy with removal of
the entire chain with excellent results for control of PH,
but our CH rate was greater than 90%. During the last
4 years, we have adapted Hsu and colleagues’ single-level
sympathectomy procedure for PH. In this study, we
achieved a significant reduction in the incidence of CH
to 13% with a single-level sympathectomy. Unfortu-
nately, our only dissatisfied patient in the T2 group was
TABLE 1. Patient characteristics by level of sympathectomy
T2 level
(n ¼ 179)
T2–T4 level
(n ¼ 103) P value
Age (y, median) 23 24 .831
Sex (no.) .912
Male 11 6
Female 168 97
Compensatory
hyperhidrosis (no.)
23 (13%) 35 (34%) .011
Morbidity (no.) 12 (7%) 9 (9%) .693The Journal of Thoracic and Cunhappy because of significant CH, even though she
had complete resolution of her PH and plantar hyperhi-
drosis.
The mechanism of CH is related to the thermoregulatory
function of the remaining sweat glands after the decrease in
function of a large number of sweat glands.7 Treatment of
CH is usually unsatisfactory. In a small number of patients,
CH may respond to anticholinergic agents, such as glyco-
pyrrolate, but the benefits are usually short-lived. A standard
sympathectomy is a permanent procedure. Therefore, if CH
develops, it is usually a permanent condition. If CH is unre-
lenting, a patient may undergo a sural nerve graft interposi-
tion to reestablish the continuity of the sympathetic chain.
Telaranta8 claims that CH can be reversed by reconstructing
the severed sympathetic trunk with a sural nerve interposi-
tion graft. The long-term results of this procedure, however,
are in question.
Another possible way to deal with CH is to perform a
reversible sympathectomy by placing clips on the nerve, in-
stead of transecting it. These clips may be removed at a later
date if CH is problematic. Lin and colleagues9 were the first
surgeons to develop and describe this potentially reversible
technique. One drawback of this procedure, however, is that
in a small but significant percentage of patients the sympa-
thetic impulse is not completely interrupted with the clips
as it would be with a complete sympathectomy. Thus the
overall satisfaction of this ’’reversible sympathectomy’’ is
reduced because of failure to eliminate the primary hyperhi-
drosis. Others have also recommended this procedure for
reversibility of CH.10-12 We have operated on several
patients who have had clips placed by other surgeons. We
were successful in removing the clips without transecting
the nerve, but none of the patients had their CH corrected.
The clips more than likely caused permanent damage to
the nerve that would not allow regrowth or acceptable sig-
naling along its path. At present, an ideal reversible
sympathectomy is not available to address the issue of post-
sympathectomy CH.
TABLE 2. Characteristics and outcomes of patientswith compensatory
hyperhidrosis
Patients with CH
(n ¼ 58)
All other
patients (n ¼ 224) P value
Level (no.) .004
T2 23 (40%) 156 (66%)
T2-T4 35 (60%) 79 (34%)
Morbidity (no.) 2 (4%) 19 (8%) .361
Body mass index
(kg/m2, median)
28.2 24.5 .048
Sex (no.)
Male 2 (3%) 15 (7%)
Female 56 (97%) 209 (93%) .218
Age (y, median) 31 23 .037
CH, Compensatory hyperhidrosis.ardiovascular Surgery c Volume 138, Number 3 583
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impact on the development of CH: multilevel sympathec-
tomy,BMI greater than28 kg/m2, and age older than31 years.
This is not the only series to show that multilevel sympathec-
tomy results in increased rate of CH.13,14 Our study is unique,
however, in that we were able to determine the difference in
incidence of postsympathectomy CH between two different
procedures for the same indication, PH, at a single institution.
The incidence of CH was almost 3-fold greater in our multi-
level sympathectomy group than in our single-level group.
Patients who seek surgery for primary PH vary in body
mass. Patients who are heavier usually experience total
body excessive sweating, rather than sweating in isolated
areas.15 Patients who have a higher BMI also usually have
more difficulty with thermoregulation.16 It is therefore not
surprising that the patients with a higher BMI (>28 kg/m2
in our series) had more CH, as was also observed by
deCampos and colleagues.17 Patients who are heavier
should be educated about their increased risk of CH after
sympathectomy and told that their increased weight may
also contribute to their underlying condition. It is essential
that before proceeding with a sympathectomy in any patient
that all conservative therapy be exhausted. If there is an issue
with excessive weight, then that should be addressed before
proceeding with a sympathectomy.
A patient’s age can also affect a wide array of diseases and
their associated outcomes. It was surprising that the patients
in our series who were older (>31 years) had more CH than
did our younger patients. The median ages of the two proce-
dural groups were similar. This is the first series of which we
are aware to show an increased incidence of CH in older
patients. Increased age may be associated with excessive
sweating because of secondary causes, such as hypertension,
diabetes, hyperthyroidism, or other endocrine problems, but
otherwise sweating usually diminishes with increasing
age.18,19 When patients who are older than 25 years and
have had symptoms for less than 5 years are referred to
our institution for treatment of hyperhidrosis, they undergo
a formal evaluation to rule out systemic disease that might
be causing excessive sweating. All the patients in this series
had primary hyperhidrosis with symptoms starting in child-
hood or adolescence. The increased rate of CH in our older
patients was not related to secondary hyperhidrosis. Older
patients should also be educated about increased risk of
CH after sympathectomy for primary PH.
Our study has several limitations. First, it was a retrospec-
tive study. The surgical data on each patient were placed into
a database prospectively, but the CH data were retrospec-
tively reviewed from the postoperative patient CH question-
naires and clinic charts. Second, this study was not
prospectively randomized for comparison between sympa-
thectomy levels of incidence of CH after sympathectomy
for PH. We believe, however, that because the operations
were performed within a single health care system for the584 The Journal of Thoracic and Cardiovascular Sursame indication in both groups and the groups were demo-
graphically equivalent that the significant difference be-
tween the groups was valid. Finally, the follow-up was
relatively short. Long-term success of this procedure has
been well-documented, with late recurrence minimal.20,21
The natural history of prolonged CH is not known, but if it
does not occur within the first 2 to 4 weeks after the sympa-
thectomy, it will not develop later.22,23 Our early results
suggest that a single-level sympathectomy for a patient
with medical refractory PH has a high success rate and
low incidence of CH.
In closing, CH can be as psychologically debilitating for
affected individuals as their primary PH. A multicenter,
prospective trial is warranted to determine at which level
a sympathectomy should be performed for PH to achieve
the greatest benefit with the lowest risk of CH. At present,
we are extremely pleased with a T2 sympathectomy for
our patients with medically refractory primary PH. Patients
who are older and those with elevated BMI should be
warned about their increased risks of CH. Ideal patient selec-
tion continues to be essential for the overall success of
sympathectomy for PH.
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